Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration
Raymond Ng, … , Niels M. Frandsen, Holger Willenbring
Raymond Ng, … , Niels M. Frandsen, Holger Willenbring
Published February 13, 2012
Citation Information: J Clin Invest. 2012;122(3):1097-1108. https://doi.org/10.1172/JCI46039.
View: Text | PDF
Research Article Hepatology

A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration

  • Text
  • PDF
Abstract

MicroRNA-21 (miR-21) is thought to be an oncomir because it promotes cancer cell proliferation, migration, and survival. miR-21 is also expressed in normal cells, but its physiological role is poorly understood. Recently, it has been found that miR-21 expression is rapidly induced in rodent hepatocytes during liver regeneration after two-thirds partial hepatectomy (2/3 PH). Here, we investigated the function of miR-21 in regenerating mouse hepatocytes by inhibiting it with an antisense oligonucleotide. To maintain normal hepatocyte viability and function, we antagonized the miR-21 surge induced by 2/3 PH while preserving baseline expression. We found that knockdown of miR-21 impaired progression of hepatocytes into S phase of the cell cycle, mainly through a decrease in levels of cyclin D1 protein, but not Ccnd1 mRNA. Mechanistically, we discovered that increased miR-21 expression facilitated cyclin D1 translation in the early phase of liver regeneration by relieving Akt1/mTOR complex 1 signaling (and thus eIF-4F–mediated translation initiation) from suppression by Rhob. Our findings reveal that miR-21 enables rapid hepatocyte proliferation during liver regeneration by accelerating cyclin D1 translation.

Authors

Raymond Ng, Guisheng Song, Garrett R. Roll, Niels M. Frandsen, Holger Willenbring

×

Figure 6

miR-21 promotes cyclin D1 translation in liver regeneration by relieving Akt1-mediated activation of mTORC1 from suppression by Rhob.

Options: View larger image (or click on image) Download as PowerPoint
miR-21 promotes cyclin D1 translation in liver regeneration by relieving...
(A) Immunoblotting showed that Rhob overexpression (OE) plasmid transfection into Hepa1,6 cells decreased levels of cyclin D1, Akt1 activated by phosphorylation at Ser473 (pAkt1), and 4E-BP1 inhibited by phosphorylation at Thr37 and/or Thr46 (p4E-BP1). Cells transfected with empty overexpression plasmid were used as control. (B) Additional Rhob knockdown (KD) with a shRNA plasmid increased cyclin D1, pAkt1, and p4E-BP1 levels. (C) Immunoblotting showed that miR-21–ASO transfection into Hepa1,6 cells increased Rhob and decreased cyclin D1, pAkt1, and p4E-BP1 levels. Additional Rhob knockdown with siRNA restored cyclin D1, pAkt1, and p4E-BP1 levels. (D) Cell cycle phase distribution analysis by flow cytometry showed Rhob-dependent accumulation of miR-21–ASO–transfected cells in G1 phase. Cells transfected with miR-21–MM-ASO and negative control siRNA were used as control. Numbers indicate protein levels relative to control. Results are representative of 3 separate experiments (Supplemental Figure 12, A–C). (E) Immunoblotting showed failure to decrease Rhob and increase pAkt1, p4E-BP1, and cyclin D1 levels in the liver after 2/3 PH in mice injected with miR-21–ASO compared with mice injected with carrier (Control) or miR-21–MM–ASO. Liver samples were obtained by 2/3 PH and 18 hours later. Numbers indicate protein levels relative to time point 0 hours after 2/3 PH. (F) Confirmation of the immunoblotting results by immunostaining (red). Original magnification, ×200; ×400 (insets). At least 3 mice were analyzed for each time point and treatment (Supplemental Figure 12D). Carrier, miR-21–MM–ASO, or miR-21–ASO was injected at 6 hours after 2/3 PH. Gapdh was analyzed as a loading control. Data represent mean ± SEM. *P < 0.05.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts